What is new in renal cell carcinoma

被引：0
作者：
Ravaud, A
Bay, JO
机构：
[1] Inst Bergonie, Ctr Reg Lutte Contre Canc, F-33076 Bordeaux, France
[2] Ctr Jean Perrin, Ctr Reg Lutte Contre Canc, F-63011 Clermont Ferrand 1, France
来源：
BULLETIN DU CANCER | 2002年 / 89卷 / 01期
关键词：
renal tumor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Authors have selected and presented radiofrequency tissue ablation for primary renal tumors and cellular therapy with dendritic cells or nonmyeloablative allogeneic transplantation as the main results in 2000-2001 on renal cell carcinoma. Furthermore other points are developed as hypertension increasing the risk of renal cell carcinoma, chromosomal events until renal cell carcinoma and prognosis of incidentally detected tumors.
引用
收藏
页码：31 / 36
页数：6
相关论文
共 23 条
[11]  
KUGLER A, 2000, NAT MED, V6, P252
[12]   Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte-macrophage colony-stimulating factor [J].
Lesimple, T ;
Moisan, A ;
Guillé, F ;
Leberre, C ;
Audran, R ;
Drenou, B ;
Toujas, L .
JOURNAL OF IMMUNOTHERAPY, 2000, 23 (06) :675-679
[13]   Impact of the number of treatment courses on the clinical response of patients who receive high-dose bolus interleukin-2 [J].
Lindsey, KR ;
Rosenberg, SA ;
Sherry, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) :1954-1959
[14]   Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer [J].
Los, M ;
Kerckhaert, OAJ ;
Zewald, R ;
van Amstel, HKP ;
Voest, EE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) :1688-1689
[15]  
Mickisch G. H., 2000, Journal of Urology, V163, P176
[16]   Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma [J].
Motzer, RJ ;
Murphy, BA ;
Bacik, J ;
Schwartz, LH ;
Nanus, DM ;
Mariani, T ;
Loehrer, P ;
Wilding, G ;
Fairclough, DL ;
Cella, D ;
Mazumdar, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2972-2980
[17]   Second primary malignancies associated with renal cell carcinoma: Influence of histologic type [J].
Rabbani, F ;
Reuter, VE ;
Katz, J ;
Russo, P .
UROLOGY, 2000, 56 (03) :399-403
[18]   Laparoscopic partial nephrectomy - The European experience [J].
Rassweiler, JJ ;
Abbou, C ;
Janetschek, G ;
Jeschke, K .
UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (04) :721-+
[19]   Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].
Slavin, S ;
Nagler, A ;
Naparstek, E ;
Kapelushnik, Y ;
Aker, M ;
Cividalli, G ;
Varadi, G ;
Kirschbaum, M ;
Ackerstein, A ;
Samuel, S ;
Amar, A ;
Brautbar, C ;
Ben-Tal, O ;
Eldor, A ;
Or, R .
BLOOD, 1998, 91 (03) :756-763
[20]  
Tannock IF, 2000, J CLIN ONCOL, V18, p39S
123